Free Trial
NASDAQ:NDRA

ENDRA Life Sciences Q2 2025 Earnings Report

ENDRA Life Sciences logo
$4.27 +0.01 (+0.23%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$4.18 -0.09 (-2.11%)
As of 09/5/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ENDRA Life Sciences EPS Results

Actual EPS
-$1.71
Consensus EPS
-$2.27
Beat/Miss
Beat by +$0.56
One Year Ago EPS
N/A

ENDRA Life Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ENDRA Life Sciences Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

ENDRA Life Sciences' Q3 2025 earnings is scheduled for Friday, November 21, 2025, with a conference call scheduled on Friday, November 14, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

ENDRA Life Sciences Earnings Headlines

6-Figure Target for BTC by 2025
Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really investing in this coin.tc pixel
ENDRA Life Sciences Inc. (NDRA) - Yahoo Finance
See More ENDRA Life Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ENDRA Life Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ENDRA Life Sciences and other key companies, straight to your email.

About ENDRA Life Sciences

ENDRA Life Sciences (NASDAQ:NDRA) develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

View ENDRA Life Sciences Profile

More Earnings Resources from MarketBeat